INVESTOR ALERT: Investigation Into Tokai Pharmaceuticals IPO Announced by Holzer & Holzer LLC
October 24 2016 - 3:27PM
Business Wire
Holzer & Holzer is investigating whether Tokai
Pharmaceuticals, Inc. (“Tokai” or the “Company”) (NASDAQ: TKAI)
issued false and misleading statements to investors in connection
with its September 18, 2014 initial public offering (the
“IPO”).
If you purchased Tokai common stock before March 17, 2015 and
suffered a loss on that investment, you are encouraged to contact
Corey D. Holzer, Esq. at cholzer@holzerlaw.com or via toll-free
telephone at (888) 508-6832, to discuss your legal rights.
Holzer & Holzer, LLC is an Atlanta, Georgia law firm that
dedicates its practice to vigorous representation of shareholders
and investors in litigation nationwide, including shareholder class
action and derivative litigation. More information about the firm
is available through its website, www.holzerlaw.com and upon
request from the firm. Holzer & Holzer, LLC has paid for the
dissemination of this promotional communication, and Corey D.
Holzer is the attorney responsible for its content.
View source
version on businesswire.com: http://www.businesswire.com/news/home/20161024006382/en/
Holzer & Holzer, LLCCorey D. Holzer, Esq., 888-508-6832
(toll-free)cholzer@holzerlaw.com
Novus Therapeutics (NASDAQ:NVUS)
Historical Stock Chart
From Mar 2024 to Apr 2024
Novus Therapeutics (NASDAQ:NVUS)
Historical Stock Chart
From Apr 2023 to Apr 2024